rs2855306

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001290003.1(THPO):​c.-29+294T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.281 in 151,838 control chromosomes in the GnomAD database, including 6,378 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.28 ( 6378 hom., cov: 31)

Consequence

THPO
NM_001290003.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.62

Publications

7 publications found
Variant links:
Genes affected
THPO (HGNC:11795): (thrombopoietin) Megakaryocytopoiesis is the cellular development process that leads to platelet production. The main functional protein encoded by this gene is a humoral growth factor that is necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis. This protein is the ligand for MLP/C_MPL, the product of myeloproliferative leukemia virus oncogene. Mutations in this gene are the cause of thrombocythemia 1. Alternative promoter usage and differential splicing result in multiple transcript variants differing in the 5' UTR and/or coding region. Multiple AUG codons upstream of the main open reading frame (ORF) have been identified, and these upstream AUGs inhibit translation of the main ORF at different extent. [provided by RefSeq, Feb 2014]
CHRD (HGNC:1949): (chordin) This gene encodes a secreted protein that dorsalizes early vertebrate embryonic tissues by binding to ventralizing TGF-beta-like bone morphogenetic proteins and sequestering them in latent complexes. The encoded protein may also have roles in organogenesis and during adulthood. It has been suggested that this gene could be a candidate gene for Cornelia de Lange syndrome. Reduced expression of this gene results in enhanced bone regeneration. Alternative splicing results in multiple transcript variants. Other alternative splice variants have been described but their full length sequence has not been determined. [provided by RefSeq, Jan 2015]
CHRD Gene-Disease associations (from GenCC):
  • congenital heart disease
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.321 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001290003.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
THPO
NM_001290003.1
c.-29+294T>C
intron
N/ANP_001276932.1
THPO
NM_001289998.1
c.-449+294T>C
intron
N/ANP_001276927.1
THPO
NM_001290028.1
c.-146+294T>C
intron
N/ANP_001276957.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
THPO
ENST00000645603.2
c.-28-920T>C
intron
N/AENSP00000494281.2
THPO
ENST00000649095.1
c.-29+294T>C
intron
N/AENSP00000497904.1
THPO
ENST00000876539.1
c.-146+1910T>C
intron
N/AENSP00000546598.1

Frequencies

GnomAD3 genomes
AF:
0.281
AC:
42576
AN:
151722
Hom.:
6374
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.254
Gnomad AMI
AF:
0.374
Gnomad AMR
AF:
0.270
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.0567
Gnomad SAS
AF:
0.208
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.324
Gnomad OTH
AF:
0.340
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.281
AC:
42599
AN:
151838
Hom.:
6378
Cov.:
31
AF XY:
0.272
AC XY:
20219
AN XY:
74222
show subpopulations
African (AFR)
AF:
0.254
AC:
10506
AN:
41350
American (AMR)
AF:
0.269
AC:
4108
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1501
AN:
3468
East Asian (EAS)
AF:
0.0566
AC:
292
AN:
5158
South Asian (SAS)
AF:
0.210
AC:
1008
AN:
4798
European-Finnish (FIN)
AF:
0.188
AC:
1985
AN:
10582
Middle Eastern (MID)
AF:
0.429
AC:
126
AN:
294
European-Non Finnish (NFE)
AF:
0.324
AC:
22028
AN:
67922
Other (OTH)
AF:
0.336
AC:
705
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1523
3045
4568
6090
7613
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.325
Hom.:
9909
Bravo
AF:
0.286
Asia WGS
AF:
0.167
AC:
583
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
10
DANN
Benign
0.81
PhyloP100
1.6
PromoterAI
0.00080
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2855306; hg19: chr3-184097085; API